Insights into a possible role of glucagon-like peptide-1 receptor agonists in the treatment of depression

[1] Wang PS(2007)Use of mental health services for anxiety, mood, and substance disorders in 17 countries in the WHO world mental health surveys Lancet 370 841-850

[2] Aguilar-Gaxiola S(2014)Innovative drugs to treat depression : did animal models fail to be predictive or did clinical trials fail to detect effects ? Neuropsychopharmacology 39 1041-1051

[3] Alonso J(1988)Clinical and biochemical manifestations of depression Relation to the neurobiology of stress (2) N Engl J Med 319 413-420

[4] Angermeyer MC(2011)Glucocorticoids, cytokines and brain abnormalities in depression Prog Neuropsychopharmacol Biol Psychiatry 35 722-729

[5] Borges G(2018)Depression Lancet 392 2299-2312

[6] Bromet EJ(2016)Plasma metabolites predict severity of depression and suicidal ideation in psychiatric patients-a multicenter pilot analysis PLoS ONE 11 e0165267-618

[7] Belzung C(2019)Association between use of oral hypoglycemic agents in Japanese patients with type 2 diabetes mellitus and risk of depression: a retrospective cohort study Pharmacol Res Perspect 7 e00536-235

[8] Gold PW(2016)Mitochondrial dysfunction in depression Curr Neuropharmacol 14 610-130

[9] Goodwin FK(2021)Gut microbiota-brain axis in depression: the role of neuroinflammation Eur J Neurosci 53 222-216

[10] Chrousos GP(2015)Depression in type 2 diabetes mellitus : prevalence, impact, and treatment Drugs 30 72-2128

[1] Wang PS(2007)Use of mental health services for anxiety, mood, and substance disorders in 17 countries in the WHO world mental health surveys Lancet 370 841-850

[2] Aguilar-Gaxiola S(2014)Innovative drugs to treat depression : did animal models fail to be predictive or did clinical trials fail to detect effects ? Neuropsychopharmacology 39 1041-1051

[3] Alonso J(1988)Clinical and biochemical manifestations of depression Relation to the neurobiology of stress (2) N Engl J Med 319 413-420

[4] Angermeyer MC(2011)Glucocorticoids, cytokines and brain abnormalities in depression Prog Neuropsychopharmacol Biol Psychiatry 35 722-729

[5] Borges G(2018)Depression Lancet 392 2299-2312

[6] Bromet EJ(2016)Plasma metabolites predict severity of depression and suicidal ideation in psychiatric patients-a multicenter pilot analysis PLoS ONE 11 e0165267-618

[7] Belzung C(2019)Association between use of oral hypoglycemic agents in Japanese patients with type 2 diabetes mellitus and risk of depression: a retrospective cohort study Pharmacol Res Perspect 7 e00536-235

[8] Gold PW(2016)Mitochondrial dysfunction in depression Curr Neuropharmacol 14 610-130

[9] Goodwin FK(2021)Gut microbiota-brain axis in depression: the role of neuroinflammation Eur J Neurosci 53 222-216

[10] Chrousos GP(2015)Depression in type 2 diabetes mellitus : prevalence, impact, and treatment Drugs 30 72-2128